ProPhase Labs Files 2024 Annual Report Amendment

Ticker: PRPH · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 868278

Prophase Labs, INC. 10-K/A Filing Summary
FieldDetail
CompanyProphase Labs, INC. (PRPH)
Form Type10-K/A
Filed DateApr 30, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: amendment, annual-report, pharmaceuticals

TL;DR

ProPhase Labs filed its 2024 10-K/A. Check for updates.

AI Summary

ProPhase Labs, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, previously known as Quigley Corp, is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its principal executive offices are located at 711 Stewart Avenue, Suite 200, Garden City, New York.

Why It Matters

This filing provides updated or corrected information for ProPhase Labs' 2024 fiscal year, which is crucial for investors to understand the company's financial health and operational status.

Risk Assessment

Risk Level: low — This is a routine amendment to an annual report, not indicating new significant risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 10-K/A filing?

This filing is an amendment to ProPhase Labs, Inc.'s annual report for the fiscal year ended December 31, 2024, indicating updates or corrections to the original filing.

What was ProPhase Labs, Inc.'s former name?

ProPhase Labs, Inc. was formerly known as Quigley Corp, with a name change date of March 28, 1993.

Where are ProPhase Labs, Inc.'s principal executive offices located?

The principal executive offices are located at 711 Stewart Avenue, Suite 200, Garden City, New York 11530.

In which state is ProPhase Labs, Inc. incorporated?

ProPhase Labs, Inc. is incorporated in Delaware.

What is the SIC code for ProPhase Labs, Inc.?

The Standard Industrial Classification (SIC) code for ProPhase Labs, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding ProPhase Labs, Inc. (PRPH).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing